Abstract
Objectives
Effective hypertension control remains low without much improvement since the 1990s. However, information is limited whether and how social status impacts on hypertension control.
Methods
Data from the German Health Survey 1998 are used to explore the role of social status according to educational achievement in treating hypertension, adjusted for key determinants in a logistic regression.
Results
Actual as well as population prevalence (≥140 mmHg/≥90 mmHg) is highest in the lowest of the three social classes with 59.4 and 51.9% as compared to 44.5 and 40.5% in the highest. Physician contacts during the previous year were also highest in the lower class with 76.0% as compared to 59.0% in the highest. The logistic regression revealed insignificant odds ratios (OR) of 1.46 for the highest and 1.12 for the middle class for treatment of known hypertension after adjusting for gender (OR for females, 1.38), age (OR for 60–69 years, 13.13), GP visits (OR, 1.43) and living in East Germany (OR, 1.56).
Conclusions
German survey data for antihypertensive treatment do not show any significant disadvantage for the lowest social class.
Similar content being viewed by others
References
Bellach BM, Knopf H, Thefeld W (1998) Der Bundes-Gesundheitssurvey 1997/98. Das Gesundheitswesen 60(Sonderheft 2):59–68
Chen R, Tunstall-Pedoe H, Morrison C et al (2003) Trends and social factors in blood pressure control in Scottish MONICA surveys 1986–1995: the rule of halves revisited. J Hum Hypertens 17:751–759
Cifkova R, Skodova Z, Lanska V et al (2004) Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/2001. J Hypertens 22(6):1479–1485
Colhoun HM, Hemingway H, Poulter NR (1998) Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens 12(2):91–110
Conen D, Glynn RJ, Ridker PM et al (2009) Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J 30(11):1378–1384
Daistra JA, Kunst AE, Borell C et al (2005) Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 34(2):316–326
De Gaudemaris R, Lang T, Chatellier G, Larabi L et al (2002) Socioeconomic inequalities in hypertension prevalence and care: the IHPAF Study. Hypertension 39:1119–1125
Forschungsverbund DHP (1998) Die Deutsche Herz-Kreislauf Praeventionsstudie. Hans Huber Publishing Company, Bern
Haijar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290(2):199–206
Hoffmeister H, Hütter H, Stolzenberg H, Lopez H, Winkler J (1992) Sozialer Status and Gesundheit. Nationaler Gesundheits-Survey 1984–86. Unterschiede in der Verteilung von Herz-Kreislauf-Krankheiten und ihrer Risikofaktoren in der Bevölkerung der Bundesrepublik Deutschland nach Schichten und Gruppen. BGA-Schriften 2/92. MMV Medizin Verlag, München
Jo I, Ahn Y, Lee J et al (2001) Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. Hypertension 19(9):1523–1532
Jonas JB, Nangia V, Matin A et al (2010) Prevalence, awareness, control, and associations of arterial hypertension in a rural central India population: the Central India Eye and Medical Study. Am J Hypertens 23(4):347–350
Jovic-Vranes A, Bjegovic-Mikanovic V, Marinkovic J (2009) Functional health literacy among primary health-care patients: data from the Belgrade pilot study. J Public Health (Oxf) 31(4):490–495
Laaser U, Breckenkamp J (2006) Trends in risk factor control in Germany 1984–1998: high blood pressure and total cholesterol. Eur J Public Health 16(2):217–222
Laaser U, Lemke-Goliasch P, Schumann V et al (1993) Behandlung und Kontrolle primärer kardiovaskulärer Risikofaktoren in den alten Bundesländern. Zeitschrift fuer Gesundheitswissenschaften 1(1):35–46
Leenen FH, Dumais J, McInnis NH et al (2008) Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 178(11):1441–1449
Loewel H, Meisinger C, Heier M et al (2006) Epidemiology of hypertension in Germany. Selected results of population representative cross-sectional studies. Dtsch Med Wochenschr 131(46):2586–2591
Macedo ME, Lima MJ, Silva AO et al (2005) Prevalence, awareness, treatment, and control of hypertension in Portugal: the PAP Study. Hypertension 23(9):1661–1666
Mathers CD, Sadana R, Salomon JA et al (2001) Healthy life expectancy in 191 countries, 1999. Lancet 357(9269):1685–1691
Meisinger C, Heier M, Voelzke H et al (2006) Regional disparities of hypertension prevalence and management within Germany. J Hypertens 24(2):293–299
Muntner P, Gu D, Wu X et al (2004) Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension 43:578–585
Murray CJL, Lopez AD (eds.) (1996a) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global burden of disease and injury series, vol. 1. Harvard University Press, Cambridge
Murray CJL, Lopez AD (eds.) (1996b) Global health statistics: a compendium of incidence, prevalence and mortality estimates for over 200 conditions. Global burden of disease and injury series, vol. 1. Harvard University Press, Cambridge
Potthoff P, Schroeder E, Reis U, Klamert A (1999) Ablauf und Ergebnisse der Feldarbeit beim Bundes-Gesundheitssurvey. Das Gesundheitswesen 61(Sonderband 2):62–67
Psaltopoulou T, Orfanos P, Naska A et al (2004) Prevalence, awareness, treatment, and control of hypertension in a general population sample of 26, 913 adults in the Greek EPIC study. Int J Epidemiol 33(6):1345–1352
Regidor E, Gutierrez-Fisac JL, Banegas JR et al (2006) Association of adult socioeconomic position with hypertension in older people. J Epidemiol Community Health 60(1):74–80
Robert Koch Institut (2011) Studie zur Gesundheit Erwachsener in Deutschland (DEGS). http://de.wikipedia.org/wiki/Bundes-Gesundheitssurvey (Accessed 05 April 2011)
Scheuch EK (1974) Sozialprestige und soziale Schichtung. in: Glass DR, König R (Hrsg) Soziale Schichtung und soziale Mobilität. Kölner Zeitschrift für Soziologie und Sozialpsychologie (Sonderheft 5)
Shah S, Cook DG (2001) Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens 19(7):1333–1340
Stolzenberg H (2000) Bundes-Gesundheitssurvey 1998. Public Use File BGS98. Dokumentation des Datensatzes, Berlin
Thamm M (1999) Blutdruck in Deutschland – Zustandsbeschreibung und Trends. Das Gesundheitswesen 61(Sonderheft 2):90–93
Thefeld W (2000) Verbreitung der Herz-Kreislauf-Risikofaktoren Hypercholesterinämie, Übergewicht, Hypertonie und Rauchen in der Bevölkerung. Bundesgesundheitsbl—Gesundheitsforsch—Gesundheitsschutz 43: 415–423
Tyroler HA (1989) Socioeconomic status in the epidemiology and treatment of hypertension. Hypertension 13(5 Suppl):194–197
Vukovic D, Bjegovic V, Vukovic G (2008) Prevalence of chronic diseases according to socioeconomic status measured by wealth index: health survey in Serbia. Croat Med J 49(6):832–841
Wang ZW, Wu YF, Zhao LC et al (2004) Trends in prevalence, awareness, treatment, and control of hypertension in middle-aged Chinese population. Zhonghua Liu Xing Bing Xue Za Zhi 25(5):407–411
Winkler J, Stolzenberg H (1999) Der Sozialschichtindex im Bundes-Gesundheitssurvey. Das Gesundheitswesen 61(Sonderheft 2):178–183
Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in six European countries, Canada, and the United States. JAMA 289(18):2363–2369
World Health Organisation, International Society of Hypertension Writing Group (2003) World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983–1992
World Health Organization (2008) Commission on social determinants of health: closing the gap in a generation. WHO, Geneva. http://www.who.int/social_determinants/thecommission/finalreport/en/index.html, visited 13 July 2010
World Health Organization (2009) Global health risks: mortality and burden of disease attributable to selected major risks. WHO, Geneva (http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf visited 13 July 2010)
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laaser, U., Breckenkamp, J. & Bjegovic, V. Treatment of hypertension in Germany: is there a social gradient?. Int J Public Health 57, 185–191 (2012). https://doi.org/10.1007/s00038-011-0274-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-011-0274-4